WO2003073997A3 - Treatment of septic shock - Google Patents
Treatment of septic shock Download PDFInfo
- Publication number
- WO2003073997A3 WO2003073997A3 PCT/US2003/006350 US0306350W WO03073997A3 WO 2003073997 A3 WO2003073997 A3 WO 2003073997A3 US 0306350 W US0306350 W US 0306350W WO 03073997 A3 WO03073997 A3 WO 03073997A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- septic shock
- positive sepsis
- treating gram
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003217862A AU2003217862A1 (en) | 2002-03-01 | 2003-03-03 | Treatment of septic shock |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36023502P | 2002-03-01 | 2002-03-01 | |
US60/360,235 | 2002-03-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003073997A2 WO2003073997A2 (en) | 2003-09-12 |
WO2003073997A3 true WO2003073997A3 (en) | 2003-11-27 |
Family
ID=27788971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/006350 WO2003073997A2 (en) | 2002-03-01 | 2003-03-03 | Treatment of septic shock |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003217862A1 (en) |
WO (1) | WO2003073997A2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6465511B1 (en) * | 1993-05-06 | 2002-10-15 | Molichem Medicines, Inc. | Treatment of septic shock |
-
2003
- 2003-03-03 AU AU2003217862A patent/AU2003217862A1/en not_active Abandoned
- 2003-03-03 WO PCT/US2003/006350 patent/WO2003073997A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6465511B1 (en) * | 1993-05-06 | 2002-10-15 | Molichem Medicines, Inc. | Treatment of septic shock |
Non-Patent Citations (2)
Title |
---|
IMSWORLD, DRUGUPDATES, R&D FOCUS, April 2002 (2002-04-01) * |
KAZMIERSKI ET AL.: "Iron chelkates bind nitric oxide and decrease mortality in an experimental model of septic shock", PROC. NATL. ACAD. SCI. USA, vol. 93, August 1996 (1996-08-01), pages 9138 - 9141, XP002967849 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003073997A2 (en) | 2003-09-12 |
AU2003217862A1 (en) | 2003-09-16 |
AU2003217862A8 (en) | 2003-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005110994A3 (en) | Substituted pyrazolyl urea derivatives useful in the treatment of cancer | |
WO2006110883A8 (en) | Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same | |
PL374191A1 (en) | 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections | |
WO2006023649A3 (en) | Treatment of severe multiple sclerosis | |
WO2003099266A3 (en) | Acetamides and benzamides that are useful in treating sexual dysfunction | |
WO2001060347A3 (en) | Method for treating ocular pain | |
WO2004080391A3 (en) | Novel antibacterial agents | |
WO2005025515A3 (en) | Proteasome pathway inhibitors and related methods | |
WO2007014762A3 (en) | Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders | |
WO2005037839A8 (en) | Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof | |
MXPA05009712A (en) | Compositions comprising hyaluronic acid for the prevention of urogenital infections. | |
EP2495245A3 (en) | Gram-positive carbapenem antibacterials and processes for their preparation | |
WO2005005436A3 (en) | Cross-linked glycopeptide-cephalosporin antibiotics | |
WO2007096703A3 (en) | Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
WO2006058720A3 (en) | Novel compounds for the treatment of neurological disorders | |
PL371205A1 (en) | Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases | |
WO2005094268A3 (en) | Treatment and prophylaxis of sepsis and septic shock | |
WO2005060693A3 (en) | 9-desoxoerythromycin compounds as prokinetic agents | |
WO2004032908A3 (en) | Method of inhibiting angiogenesis | |
WO2006089286A3 (en) | Triazadibenzoazulene compounds useful for the treatment and prevention of pain and screening methods therefor compounds useful for the treatment and prevention of pain and screening methods therefor | |
WO2004019879A3 (en) | Motilide compounds | |
WO2004033423A3 (en) | Anticancer compounds | |
UA83203C2 (en) | Thiazol-(bi)cycloalkyl-carboxanilides and their use for fighting against undesirable microorganisms | |
WO2005041904A3 (en) | Inhibitors of coronavirus protease and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |